WiseGuyReports.Com Publish a New Market Research Report On –“ Car T Cell Therapy 2019 Global Market Outlook,Research,Trends and Forecast to 2025”.
The Global CAR T Cell Therapy Market is anticipated to register a CAGR of 58.52% to attain USD 8716.06 Million by the year 2025. Chimeric Antigen Receptor (CAR) T Cell Therapy is an immunotherapy that is used for cancer treatment. In this therapy, T cells from patient body are separated and introduced in the CAR gene so that the gene for the specific receptor binds to a certain protein on the patient’s cancer cells. The rising incidence of cancer across the world, technological advancement for advanced & reliable treatment for cancer, growing pharmaceutical industry, and growth in the number of cell therapy clinical studies are pushing the growth of the global CAR T cell therapy market. However, side-effects of CAR T-cell therapy and high cost of treatment are likely to hinder the market growth. Growing frequency of cancer across the world, technological progress for advanced & reliable treatment for cancer, and increase in the number of cell therapy clinical studies are pushing the growth of the global CAR T cell therapy market. According to the National Cancer Institute, it is estimated that 1,735,350 new cases of cancer were diagnosed, and 609,640 deaths were reported in the US in 2018. Moreover, the growing pharmaceutical industry is also expected to boost market growth. One of the main strategies followed by players operating in the global CAR T cell therapy market were innovation, product growth, and acquisitions & mergers. In April 2019, Autolus Therapeutics PLC was granted with an orphan drug designation, to autologous improved T-cells, inherently altered with a retroviral vector to express two chimeric antigen receptors targeting CD19 and CD22 (AUTO3) for the treatment of severe lymphoblastic leukemia (ALL), by the US FDA.
For more information or any query mail at email@example.com
Key Players Analysis
The proposed spectators in the global CAR T cell therapy market are Hospitals, Pharmaceutical companies, Biotechnology Companies, Research institutes, Contract Research Organizations, Academic institutes. The major companies functioning in the global CAR T cell therapy market are concentrating on firming their global ways by entering into untouched markets. Pfizer, Inc. (US), Kite Pharma (US), Cellectis (France), Autolus Therapeutics PLC (UK), uno Therapeutics (US), Sorrento Therapeutics (US), (US), Mustang Bio (US), Novartis AG (Switzerland), CARsgen Therapeutics (China), Legend Biotech and others are some of the prominent players in the global CAR T cell therapy market.
The growing trend of the industries, the performance of the market players, and the macro-economic outlook of the current market scenario are taken into consideration to predict the forecast of the Car T Cell Therapy market. The report emphasizes on the prime factors governing the growth of the market, like opportunities and threats, drivers, and restraints.
The report ensures an objective analysis of the Car T Cell Therapy market by engaging a set of standards, allowing a comprehensive view of the market and its several components. Factors comprising economic growth, government expenditure, supply channels, and distribution channels have been scrutinized effort to relay precise information. Market size estimation and validation using top-down and bottom-up approaches ash been performed in order to obtain data from the demand and supply side. Analysis of data has been performed by using a research framework suited to the specific industry. The frameworks serve as a research standard that provides tools to create dependable market reports.
Global CAR T Cell Therapy Market has been segmented by Target Antigen, by application, and by region. Based on target antigen the market has been split into CD19, CD22, and Others. Based on application, the global CAR T Cell Therapy Market has been divided into Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma and Others. On the basis of region, the global CAR T Cell Therapy Market, by Region has been segmented US, Europe, China and Rest of the World.
Table Of Contents – Major Key Points
- Executive Summary
- Market Introduction
- Research Methodology
- Market Dynamics
- Industry Analysis—Porter’s Five Forces Model
- Global CAR T Cell Therapy Market, By Target Antigen
- Global CAR T Cell Therapy Market, By Application
- Global CAR T Cell Therapy Market, By Region
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.